dorzolamide-timolol combination (Cosopt)

Subscribe to Selected New Research on dorzolamide-timolol combination

20 relevant articles (1 outcomes, 1 trials/studies) found for this Drug

Description: for glaucoma/ocular hypertensive patients; a fixed combination of timolol (Adrenergic beta-Antagonists) and dorzolamide (Carbonic Anhydrase Inhibitor)

Also Known As:

Cosopt; dorzolamide hydrochloride-timolol maleate combination

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 25

1-Ring Heterocyclic Compounds

dorzolamide-timolol combination: 20

Thiophenes: 11

dorzolamide-timolol combination: 20

Oxazines: 1

Morpholines: 2

Timolol: 1308

dorzolamide-timolol combination: 20

Pharmaceutical Preparations

Drug Combinations: 850

dorzolamide-timolol combination: 20

Experts

1.	Fechtner, Robert D: 1 article (02/2004)
2.	Airaksinen, P Juhani: 1 article (02/2004)
3.	COSOPT versus XALATAN Study Groups: 1 article (02/2004)
4.	Lines, Christopher R: 1 article (02/2004)
5.	Adamsons, Ingrid A: 1 article (02/2004)
6.	Getson, Albert J: 1 article (02/2004)
7.	Whitcup, Scott M: 1 article (12/2003)
8.	Lerner, Fabian: 1 article (12/2003)
9.	Bernstein, Paula: 1 article (12/2003)
10.	Coleman, Anne L: 1 article (12/2003)

Related Diseases

1.	Cataract (Cataracts) 09/01/2003 - "CONCLUSIONS: The fixed dorzolamide-timolol combination was effective in reducing IOP 6 hours and 20 to 24 hours after cataract surgery. " 10/01/2007 - "All patients had standardized cataract surgery with PPCCC and IOL implantation in the capsular bag followed by a postoperative dose of a fixed dorzolamide-timolol combination. " 09/01/2003 - "Patients were randomized to receive 1 drop of the fixed dorzolamide-timolol combination in 1 eye or no treatment (control) immediately after cataract surgery. " 10/01/2007 - "PURPOSE: To assess the safety, in terms of the intraocular pressure (IOP), of cataract surgery with primary posterior continuous curvilinear capsulorhexis (PPCCC) and a postoperative dose of a fixed dorzolamide-timolol combination and evaluate the effect of intraocular lens (IOL) haptic angulation. " 09/01/2003 - "Effect of a fixed dorzolamide-timolol combination on intraocular pressure after small-incision cataract surgery with Viscoat." Order ALL the reference details at left...
2.	Glaucoma 01/01/2008 - "[The role of Cosopt in glaucoma treatment]" 01/01/2008 - "Current commercially available fixed combinations used in glaucoma treatment include Combigan, Cosopt, Xalcom, Duotrav and Ganfort. " 01/01/2003 - "Ophthalmologists were asked to report their experience with COSOPT therapy prescribed to patients with glaucoma or ocular hypertension. " 01/01/2004 - "Cosopt or latanoprost as primary glaucoma therapy?" 08/01/2009 - "Dorzolamide-timolol combination and retinal vessel oxygen saturation in patients with glaucoma or ocular hypertension." Order ALL the reference details at left...
3.	Ocular Hypertension (Glaucoma, Suspect) 01/01/2008 - "after the failure of a previously given monotherapy Cosopt is also indicated as an initial therapy (first line therapy) in ocular hypertensions associated with high risk factors of conversion, in some well chosen cases of primary open-angle glaucoma (e.g. " 01/01/2003 - "Ophthalmologists were asked to report their experience with COSOPT therapy prescribed to patients with glaucoma or ocular hypertension. " 08/01/2009 - "Dorzolamide-timolol combination and retinal vessel oxygen saturation in patients with glaucoma or ocular hypertension." 06/01/2005 - "By the measures used in this analysis, the dorzolamide/timolol combination and latanoprost were equally effective at lowering IOP in patients with ocular hypertension or glaucoma." 11/01/1998 - "METHODS: After a 2 week timolol run in, patients with open angle glaucoma or ocular hypertension were randomised (1:1) to receive treatment with either the dorzolamide/timolol combination solution twice daily (combination) or the dorzolamide solution twice daily plus timolol maleate solution twice daily (concomitant) for 3 months. " Order ALL the reference details at left...
4.	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/01/2008 - "after the failure of a previously given monotherapy Cosopt is also indicated as an initial therapy (first line therapy) in ocular hypertensions associated with high risk factors of conversion, in some well chosen cases of primary open-angle glaucoma (e.g. " 10/01/2001 - "Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma." 10/01/2001 - "CONCLUSIONS: When compared with timolol in primary open-angle glaucoma, Cosopt augments ocular tension reduction and reduces the amount of time required for blood to pass through the superior retinal vasculature." 11/01/1998 - "METHODS: After a 2 week timolol run in, patients with open angle glaucoma or ocular hypertension were randomised (1:1) to receive treatment with either the dorzolamide/timolol combination solution twice daily (combination) or the dorzolamide solution twice daily plus timolol maleate solution twice daily (concomitant) for 3 months. " 09/01/2008 - "A patient preference comparison of Azarga (brinzolamide/timolol fixed combination) vs Cosopt (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension." Order ALL the reference details at left...
5.	Retinal Detachment (Retinal Detachments) 11/01/2003 - "The second patient, a 43-year-old Haitian male, developed a central serous retinal detachment OS with decreased visual acuity one day following in-office administration of Apraclonidine (0.5 per cent Iopidine, Alcon) and Dorzolamide-Timolol Maleate (Cosopt, Merck) to lower elevated intraocular pressure (IOP). " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Timolol (Blocadren)
2.	dorzolamide (Trusopt)
3.	latanoprost (Xalatan)
4.	Carbonic Anhydrases (Carbonic Anhydrase)
5.	dorzolamide-timolol combination (Cosopt)
6.	brinzolamide (Azopt)
7.	brimonidine (Alphagan)
8.	Adrenergic Antagonists (Antiadrenergic Agents)
9.	Betaxolol (Kerlon)
10.	Smog

Related Therapies and Procedures

1.	Capsulorhexis
2.	Intraocular Lenses (Intraocular Lens)

Best Treatments:
Research Summary Report
on Cataract

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 628 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>